Intuitive Surgical (NASDAQ:ISRG) PT Raised to $549.00 at Wells Fargo & Company

Intuitive Surgical (NASDAQ:ISRG) had its price objective upped by research analysts at Wells Fargo & Company from $466.00 to $549.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an “overweight” rating on the medical equipment provider’s stock. Wells Fargo & Company‘s target price indicates a potential upside of 6.81% from the company’s previous close.

A number of other research firms also recently issued reports on ISRG. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday. Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and boosted their target price for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Truist Financial boosted their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a report on Monday. Piper Sandler restated an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday. Finally, Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $496.95.

Intuitive Surgical Trading Up 8.5 %

Shares of NASDAQ ISRG traded up $40.27 during midday trading on Friday, reaching $514.00. 1,460,579 shares of the stock were exchanged, compared to its average volume of 1,464,988. The company has a market capitalization of $182.32 billion, a P/E ratio of 92.56, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 52-week low of $254.85 and a 52-week high of $517.61. The stock has a 50 day moving average price of $482.69 and a 200-day moving average price of $436.91.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the previous year, the firm posted $1.18 earnings per share. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, analysts forecast that Intuitive Surgical will post 5.22 earnings per share for the current year.

Insider Activity

In other news, EVP Robert Desantis sold 1,413 shares of the company’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,414,931.60. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, General Counsel Gary Loeb sold 300 shares of the stock in a transaction on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the transaction, the general counsel now directly owns 1,595 shares in the company, valued at $757,625. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Robert Desantis sold 1,413 shares of the stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 53,120 shares of company stock worth $25,528,753. 0.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Mirador Capital Partners LP boosted its stake in Intuitive Surgical by 1.4% during the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in Intuitive Surgical by 18.1% during the 1st quarter. Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock valued at $2,945,000 after acquiring an additional 1,129 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Intuitive Surgical by 617.1% during the 2nd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Brookstone Capital Management boosted its stake in Intuitive Surgical by 22.4% during the 2nd quarter. Brookstone Capital Management now owns 12,530 shares of the medical equipment provider’s stock valued at $5,340,000 after acquiring an additional 2,289 shares during the last quarter. Finally, M&G Plc boosted its stake in Intuitive Surgical by 53.5% during the 2nd quarter. M&G Plc now owns 5,069 shares of the medical equipment provider’s stock valued at $2,256,000 after acquiring an additional 1,766 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.